%0 Generic
%T Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma
%A Wick, Antje
%A Desjardins, Annick
%A Suárez García, Cristina
%A Forsyth, Peter
%A Gueorguieva, Ivelina
%A Burkholder, Tiana
%A Cleverly, Ann Louise
%A Estrem, Shawn T.
%A Wang, Shuaicheng
%A Lahn, Michael M.
%A Guba, Susan C.
%A Capper, David
%A Rodon, Jordi
%@ 1573-0646
%D 05 March 2020
%X Gesehen am 18.11.2021
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation